GeekGenome Editor CRISPR Targets AIDS Virus HIVGeekUsing CRISPR, the team was able to destroy these genes and successfully block the production of HIV-1 by infected cells. “These results show that the CRISPR/Cas9 system, by targeting the regulatory gen… Continue reading
GeekGenome Editor CRISPR Targets AIDS Virus HIVGeekUsing CRISPR, the team was able to destroy these genes and successfully block the production of HIV-1 by infected cells. “These results show that the CRISPR/Cas9 system, by targeting the regulatory gen… Continue reading
GeekGenome Editor CRISPR Targets AIDS Virus HIVGeekUsing CRISPR, the team was able to destroy these genes and successfully block the production of HIV-1 by infected cells. “These results show that the CRISPR/Cas9 system, by targeting the regulatory gen… Continue reading
GeekGenome Editor CRISPR Targets AIDS Virus HIVGeekUsing CRISPR, the team was able to destroy these genes and successfully block the production of HIV-1 by infected cells. “These results show that the CRISPR/Cas9 system, by targeting the regulatory gen… Continue reading
Dr. McGregor on New Combinations With Immunotherapy in RCCOncLiveIn addition to the 2 recent phase III trials, CheckMate-214 and IMmotion151, there are emerging combinations with immunotherapy showing promise in RCC. There are currently clinical trials… Continue reading
OncLiveDr. McGregor on New Combinations With Immunotherapy in RCCOncLiveIn addition to the 2 recent phase III trials, CheckMate-214 and IMmotion151, there are emerging combinations with immunotherapy showing promise in RCC. There are currently clinical… Continue reading
OncLiveDr. McGregor on New Combinations With Immunotherapy in RCCOncLiveIn addition to the 2 recent phase III trials, CheckMate-214 and IMmotion151, there are emerging combinations with immunotherapy showing promise in RCC. There are currently clinical… Continue reading
Endpoints News |
FDA chief Gottlieb is building a regulatory speedway to accelerate gene therapy development
Endpoints News Gottlieb discussed the FDA’s policy plans for gene therapy Tuesday at the annual board meeting of the Alliance for Regenerative Medicine. Quoting an MIT study that predicts 40 FDA-approved gene therapy products by the end of 2022, he acknowledged … Gene Therapies That Could Transform Diseases Get Easier FDA …Bloomberg FDA plans to speed path to approval for some gene therapies – StatSTAT Gene therapies get easier path to FDA approvalSFGate Regulatory Focus –StreetInsider.com all 7 news articles » |